0001609251-23-000004.txt : 20230811 0001609251-23-000004.hdr.sgml : 20230811 20230811153718 ACCESSION NUMBER: 0001609251-23-000004 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 EFFECTIVENESS DATE: 20230811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Krensavage Asset Management, LLC CENTRAL INDEX KEY: 0001609251 IRS NUMBER: 262520930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16807 FILM NUMBER: 231163690 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 212-888-1582 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE STREET 2: SUITE 301 CITY: NEW YORK STATE: NY ZIP: 10020 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001609251 XXXXXXXX 06-30-2023 06-30-2023 Krensavage Asset Management, LLC

610 FIFTH AVENUE SUITE 301 NEW YORK NY 10020

13F HOLDINGS REPORT 028-16807 N Paul J. Paolino 212-518-3193 /s/ Paul J. Paolino New York NY 08-11-2023 0 12 315622 false INFORMATION TABLE 2 krensavage_13f_06.30.2023.xml KRENSAVAGE FORM 13F 06.30.2023 ALKERMES PLC COM G01767105 34538 1103451 SH SOLE 1395797 0 0 BIOGEN INC COM 09062X103 50369 176826 SH SOLE 177126 0 0 CARDINAL HEALTH INC COM 14149Y108 33451 353714 SH SOLE 353278 0 0 EAGLE PHARMACEUTICALS INC COM 269796108 2205 113437 SH SOLE 113737 0 0 EMBECTA CORP COM 29082K105 23129 1070810 SH SOLE 1062123 0 0 ENANTA PHARMACEUTICALS INC COM 29251M106 14715 687613 SH SOLE 603301 0 0 EXELIXIS INC COM 30161Q104 40775 2133703 SH SOLE 2135868 0 0 KODIAK SCIENCES INC COM 50015M109 2378 344634 SH SOLE 459489 0 0 REGENERON PHARMACEUTICALS COM 75886F107 42529 59188 SH SOLE 59488 0 0 TARO PHARMACEUTICAL INDUS COM M8737E108 24392 643080 SH SOLE 641910 0 0 UNITED THERAPEUTICS CORP COM 91307C102 44749 202715 SH SOLE 202110 0 0 VANDA PHARMACEUTICALS INC COM 921659108 2392 362951 SH SOLE 361560 0 0